The FDA held its first hearing on CBD—here's what four industry experts had to say

The Food and Drug Administration held its first hearing on the safety and regulation of CBD, or cannabidiol. Researchers, doctors and manufacturers all testified on the need for rules and regulations on the substance. CBD has gained a rush of new popularity in recent months, but little is known about the substance as research is still being conducted.


Comments are closed, but trackbacks and pingbacks are open.